Biotechnology Value Fund, L.P. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (231)	7/27/1998 2:47:00 PM
From: JMarcus	of 4974

Isn't the flip side to heavy shorting of stocks with a share price under $5 (in his II presentation Peter Freudenthal said institutional investors are doing this more and more) that when one of those stocks takes off on enthusiasm over an outstanding news event, the price might soar all the more as the shorts scramble for cover? There remains the general negative, however, that the downward pressure from the shortside is making it more and more difficult for the small biotech companies to attract financing on favorable terms (unless they have just released exciting news). On the brighter side, both analysts at the II forum predicted a rebound in biotech stock prices come September, when all the brokers return from summer vacation and a host of medical conferences begin spreading the latest news of pending trials.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next